Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
3
Neutral
4
Bullish
7
Bearish
24
Neutral
12
Bullish
10
Bearish
21
Neutral
8
Bullish
3
Discovery themes featuring this stock
Walpar Nutritions Limited is engaged in the manufacturing, marketing, and trading of pharmaceuticals, nutraceuticals, herbal, and Ayurvedic products both online and offline.
The company evolved from a partnership firm into a public limited company with roots dating back to 2009, emphasizing its strong foundation in the nutraceutical domain.
Significant growth was marked by international market engagement, where Walpar expanded its footprint by exporting to countries like Nigeria, Vietnam, and Bangladesh.
The company has strengthened its manufacturing capabilities, especially in producing custom nutrition solutions, highlighting its adaptability to market demands.
Its diverse range of licenses, including FSSAI and AYUSH, enable it to manufacture a wide array of health-focused products.
Pharmaceuticals & Biotechnology
Pharmaceuticals
22 Cr
Moderate Risk
8.8
34.3
0.1
1.2
51.80
21.25
Sales CAGR
Profit CAGR
ROE
ROCE
Walpar Nutritions Ltd (WALPAR) is currently trading at 23.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Walpar Nutritions Limited is engaged in the manufacturing, marketing, and trading of pharmaceuticals, nutraceuticals, herbal, and Ayurvedic products both online and offline. The company evolved from a partnership firm into a public limited company with roots dating back to 2009, emphasizing its strong foundation in the nutraceutical domain. Significant growth was marked by international market engagement, where Walpar expanded its footprint by exporting to countries like Nigeria, Vietnam, and Bangladesh. The company has strengthened its manufacturing capabilities, especially in producing custom nutrition solutions, highlighting its adaptability to market demands. Its diverse range of licenses, including FSSAI and AYUSH, enable it to manufacture a wide array of health-focused products.
Over the past 52 weeks, Walpar Nutritions Ltd has traded between a low of ₹21.25 and a high of ₹51.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Walpar Nutritions Ltd has a market capitalization of approximately 21.79. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Walpar Nutritions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.82 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 21.79 Cr, Walpar Nutritions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Walpar Nutritions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Walpar Nutritions Ltd is 8.82. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
20.00 | 23 Cr | 115.85 | 1.64 | 0.00 | 1.76 | 1.92 | 1.23 | ||
74.70 | 22 Cr | 28.77 | 1.94 | 0.00 | 6.73 | 9.78 | 6.19 | ||
59.32 | 22 Cr | -5.35 | 0.00 | 0.00 | 67.65 | -85.76 | -14.80 | ||
40.00 | 22 Cr | 14.58 | 0.94 | 0.00 | 6.49 | 7.62 | 0.44 | ||
23.20 | 22 Cr | 8.82 | 1.15 | 0.00 | 13.09 | 13.74 | 4.84 | ||
8.26 | 21 Cr | -0.89 | 2.42 | 0.00 | -117.84 | -25.84 | -37.84 | ||
11.65 | 21 Cr | 24.80 | 0.66 | 0.00 | 2.67 | 6.38 | 0.70 | ||
| Median: 7 Co. | — | 23.20 | 22 Cr | 14.58 | 1.15 | 0.00 | 6.49 | 6.38 | 0.70 |
